Sign in
Synthetic BiologybioRxiv
Preprint

A synthetic receptor platform enables rapid and portable monitoring of liver dysfunction via engineered bacteria.

Hung‐Ju ChangiD, Ana ZúñigaiD, Ismaël ConejeroiD, Peter L. VoyvodiciD, Jérôme GracyiD, Elena Fajardo-RuiziD, Martin Cohen‐GonsaudiD, Guillaume CambrayiD, Georges‐Philippe PageauxiD, Magdalena MeszarosiD, Lucy MeunieriD, Jerome BonnetiD

Abstract

Bacterial biosensors, or bactosensors, are promising field-deployable agents for medical and environmental diagnostics. However, the lack of scalable frameworks to systematically program ligand detection limits their applications. Here we present a synthetic receptor platform, termed EMeRALD (Engineered Modularized Receptors Activated via Ligand-induced Dimerization) which supports the modular assembly of sensing modules onto a high-performance, generic signaling scaffold controlling gene expression in E. coli. We applied EMeRALD to detect bile salts, a biomarker of liver dysfunction, by repurposing sensing modules from enteropathogenic Vibrio species. We improved the sensitivity and lowered the limit-of-detection of the sensing module by directed evolution. We then engineered a colorimetric bactosensor detecting pathological bile salt levels in serum from patients having undergone liver transplant, providing an output detectable by the naked-eye. The EMeRALD technology enables functional exploration of natural sensing modules and rapid engineering of synthetic receptors for diagnostics, environmental monitoring, and control of therapeutic microbes.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.